Chapter 2 - The Toxicology Report
The rain began two hours after the police carried Callista out of the chapel. It pounded against the glass windows of Dr. Samuel Hendricks’s private office at the St. Jude Pediatric Research Center.
I sat in a stiff leather chair across from him. Uncle David sat to my left, holding a thick legal pad. On the wooden desk between us sat three items: Emma's medical folder, a sealed biohazard bag containing the brown prescription bottle, and a steaming cup of tea that neither of us had touched.
Dr. Hendricks looked ten years older than he had three weeks ago. He pulled off his wire-rimmed glasses and rubbed the bridge of his nose, staring down at a set of lab printouts.
"I’ve spent thirty years in pediatric medicine, Lia," Dr. Hendricks said, his voice raspy with exhaustion. "I’ve seen terrible diseases. I’ve seen bad luck, failed treatments, and heartbreaking anomalies. But I have never... never in my entire career seen anything like this."
"Tell me what was in the bottle, Doctor," I said. My voice was unnaturally flat. Grief had built a hard, crystalline shell around my emotions. I couldn't afford to break down—not yet.
Dr. Hendricks slid a piece of paper across the desk toward us.
"The yellow pills—the actual experimental drug, Vascularis-9—were designed to rebuild the micro-vessels around Emma’s tumor while keeping her systemic blood pressure lowered," he explained, pointing at a chemical breakdown chart. "The white pills Callista replaced them with were not placebos or sugar tablets. They were a compound called Duralene-4."
Uncle David leaned in. "What is Duralene-4?"
"It’s an aggressive, short-acting anti-hypertensive binder," Dr. Hendricks said softly. "In an adult with high blood pressure, it’s harmless. But in a child of Emma’s size, whose system was reliant on Vascularis-9, it acted as a chemical trigger. It didn't just fail to treat her condition—it actively accelerated her vascular collapse within forty-eight hours."
I closed my eyes. In my mind, I saw Emma lying in her bed four days ago, pointing at her chest and saying her heart felt like a fluttering bird. I had held her hand, smoothed her hair, and told her the medicine was just working hard to make her better. I had given her a sip of water and kissed her forehead while the poison flushed through her tiny veins.
"It was murder," Uncle David said, his voice dropping to a dangerous whisper.
"Medically speaking? Yes," Dr. Hendricks replied. "It was systematic organ failure induced by intentional compound substitution. But there’s something worse, Lia."
I opened my eyes. "Worse?"
Dr. Hendricks unlocked his bottom desk drawer and pulled out a thick, leather-bound binder stamped with the logo of Aegis Bio Corp.
"When Callista was arrested, the police seized her personal laptop from her car," Dr. Hendricks revealed. "Her attorney tried to have the drive wiped remotely using a cloud command, but the precinct’s cyber-forensics team intercepted the transmission. They recovered forty gigabytes of encrypted emails between Callista and a man named Marcus Kane."
"Who is Marcus Kane?" I asked.
"He is the Chief Legal Counsel and Vice President of Risk Assessment for Aegis Bio Corp," Dr. Hendricks said, his face darkening. "Lia, Emma wasn't the only child in Phase II of this trial. There were forty-two children across six hospitals in the tri-state area."
A cold dread pooled in my stomach. "What are you saying?"
"The trial was a disaster from a financial standpoint," Dr. Hendricks explained, turning the binder toward us. "The drug was working on the pediatric patients, but the manufacturing process cost over two hundred thousand dollars per dose. Aegis was going under. Their stock was collapsing. However, they had a massive insurance policy—a three-billion-dollar fail-safe clause—if the trial had to be terminated due to 'unforeseen catastrophic patient non-viability.'"
Uncle David stood up so fast his chair scraped loudly against the floor. "They deliberately sabotaged the drug to fail the trial and collect the insurance payout?"
"If the trial simply failed due to lack of efficacy, Aegis lost everything," Dr. Hendricks said quietly. "But if the trial produced sudden, fatal complications across target subjects, the drug would be declared a biological hazard, the trial would be immediately sealed by federal mandate, and Aegis would collect the entire liability settlement from their underwriters. Callista wasn't acting alone. She was the inside operative assigned to ensure the 'fatal complications' occurred in our hospital cluster."
"How many children?" I asked. My heart felt like it was hammering against a wall of ice. "How many other children did they do this to?"
Dr. Hendricks looked down at the floor, unable to meet my eyes.
"Twelve children were in Emma's sub-group," he whispered. "Four of them passed away last week. Five more are currently in critical care in Philadelphia."
The horror of it hit me like a physical blow. Emma’s death wasn't just a family tragedy or an act of personal jealousy from Callista. It was a cold, calculated, mass execution performed in broad daylight by suit-wearing monsters for a corporate balance sheet.
"They think they’re untouchable," Uncle David said, turning to me. "Aegis has top-tier defense firms, political connections, and billions of dollars. They will drag Callista’s trial out for ten years until everyone forgets, or they'll frame her as a rogue actor and walk away clean."
"No," I said.
I stood up. I reached out and took the biohazard bag containing Emma’s bottle from the desk. I looked at Dr. Hendricks.
"They think I’m just a grieving mother who will sit in a dark room and cry until I fade away," I said, my voice steady, clear, and stripped of all hesitation. "They think because my baby is dead, I have nothing left to fight with."
May you like
I looked down at the stuffed rabbit in my arm.
"They don't realize that a mother with nothing left to lose is the most dangerous person on earth."
